Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Guida

Showing results (131-140 of 172) with videos related to

Pageof 18
Sort By:
Clinical Chemistry|January 1, 1995
A molecular protocol for diagnosing myotonic dystrophyM Guida, R S Marger, A C Papp, et al.
International Journal of Immunopathology and Pharmacology|February 9, 2005
TNF-alpha serum level elevations in chronic hepatitis C patients with diabetes mellitusA Perrella, G Borgia, F Borrelli, et al.
Translational Medicine @ Unisa|August 2, 2013
Estrogens and neuropeptides in postmenopausal women: un updateM Guida, F Zullo, B Buonomo, et al.
European Journal of Cancer (Oxford, England : 1990)|March 10, 2001
Paclitaxel, cisplatin and lonidamine in advanced ovarian cancer. A phase II studyM De Lena, V Lorusso, A Latorre, et al.
The Science of the Total Environment|January 15, 2018
Effects of ZnO nanoparticles in the Caspian roach (Rutilus rutilus caspicus)K Khosravi-Katuli, G Lofrano, H Pak Nezhad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 23, 1997
Revertant and potentiating activity of lonidamine in patients with ovarian cancer previously treated with platinumM De Lena, V Lorusso, C Bottalico, et al.
Human Genetics|August 1, 1996
Mutational spectrum in the neurofibromatosis type 2 gene in sporadic and familial schwannomasD B Welling, M Guida, F Goll, et al.
British Journal of Cancer|May 26, 2011
Central nervous system failure in melanoma patients: results of a randomised, multicentre phase 3 study of temozolomide- and dacarbazine- based regimensV Chiarion-Sileni, M Guida, L Ridolfi, et al.
Clinical Pharmacology and Therapeutics|October 8, 1999
Population distribution and effects on drug metabolism of a genetic variant in the 5' promoter region of CYP3A4S E Ball, J Scatina, J Kao, et al.
Virchows Archiv : an International Journal of Pathology|January 1, 1995
Changes in E-cadherin immunoreactivity in the adenoma-carcinoma sequence of the large bowelG Gagliardi, O Kandemir, D Liu, et al.
Pageof 18

Showing results (131-140 of 172) with videos related to

Sort By:
Pageof 18
Clinical Chemistry|January 1, 1995
A molecular protocol for diagnosing myotonic dystrophyM Guida, R S Marger, A C Papp, et al.
International Journal of Immunopathology and Pharmacology|February 9, 2005
TNF-alpha serum level elevations in chronic hepatitis C patients with diabetes mellitusA Perrella, G Borgia, F Borrelli, et al.
Translational Medicine @ Unisa|August 2, 2013
Estrogens and neuropeptides in postmenopausal women: un updateM Guida, F Zullo, B Buonomo, et al.
European Journal of Cancer (Oxford, England : 1990)|March 10, 2001
Paclitaxel, cisplatin and lonidamine in advanced ovarian cancer. A phase II studyM De Lena, V Lorusso, A Latorre, et al.
The Science of the Total Environment|January 15, 2018
Effects of ZnO nanoparticles in the Caspian roach (Rutilus rutilus caspicus)K Khosravi-Katuli, G Lofrano, H Pak Nezhad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 23, 1997
Revertant and potentiating activity of lonidamine in patients with ovarian cancer previously treated with platinumM De Lena, V Lorusso, C Bottalico, et al.
Human Genetics|August 1, 1996
Mutational spectrum in the neurofibromatosis type 2 gene in sporadic and familial schwannomasD B Welling, M Guida, F Goll, et al.
British Journal of Cancer|May 26, 2011
Central nervous system failure in melanoma patients: results of a randomised, multicentre phase 3 study of temozolomide- and dacarbazine- based regimensV Chiarion-Sileni, M Guida, L Ridolfi, et al.
Clinical Pharmacology and Therapeutics|October 8, 1999
Population distribution and effects on drug metabolism of a genetic variant in the 5' promoter region of CYP3A4S E Ball, J Scatina, J Kao, et al.
Virchows Archiv : an International Journal of Pathology|January 1, 1995
Changes in E-cadherin immunoreactivity in the adenoma-carcinoma sequence of the large bowelG Gagliardi, O Kandemir, D Liu, et al.
Pageof 18